Completed × NETWORK × Other hematologic neoplasm × Clear all A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative Disorders
Phase 1/2 Completed
58 enrolled
BMT CTN 1702
Phase NA Completed
1,753 enrolled
Long Term Safety and Efficacy of KSM-66 Ashwagandha in Adults
Completed
200 enrolled
HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide
Phase 2 Completed
80 enrolled 56 charts
CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7
Phase 2 Completed
52 enrolled
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
Phase 2 Completed
196 enrolled 26 charts
MoVeUP
Phase NA Completed
1,934 enrolled 11 charts
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Completed
301 enrolled
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Phase 3 Completed
727 enrolled 13 charts
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
Phase 3 Completed
292 enrolled 12 charts
Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation
Completed
252 enrolled
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase 3 Completed
218 enrolled 21 charts
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Phase 3 Completed
275 enrolled 14 charts
Effect of 2nd Gen TKI in CML
Completed
432 enrolled
BMT CTN 1704
Completed
1,229 enrolled
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Completed
174 enrolled
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Completed
17,463 enrolled
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
Phase 2 Completed
127 enrolled 20 charts
Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia
Phase 2 Completed
14 enrolled 9 charts
Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Completed
35 enrolled
Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Phase 1/2 Completed
21 enrolled
A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia
Phase 1 Completed
12 enrolled
A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia
Phase 2 Completed
7 enrolled
Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL
Phase 2 Completed
102 enrolled 11 charts
Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
Phase 3 Completed
744 enrolled
Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia
Phase 2 Completed
Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
Phase 2 Completed
Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
Phase 2 Completed
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Completed
1,873 enrolled
Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
Phase 3 Completed
280 enrolled
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Phase NA Completed
434 enrolled
Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma
Phase 2 Completed
77 enrolled
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
Phase 3 Completed
657 enrolled 8 charts
S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia
Phase 1 Completed
50 enrolled 14 charts
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
Phase 3 Completed
838 enrolled
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase 3 Completed
1,076 enrolled
CHRONOS19
Completed
666 enrolled
S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Phase 2 Completed
78 enrolled 8 charts
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
Phase 3 Completed
106 enrolled 14 charts
Concealed Penis in Pediatric Age Group
Phase NA Completed
150 enrolled
DNA Analysis of Tumor Tissue Samples From Young Patients With Acute Lymphoblastic Leukemia
Completed
520 enrolled
Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
Completed
2,000 enrolled
Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases
Phase 3 Completed
27 enrolled 13 charts
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Phase 3 Completed
205 enrolled 19 charts
EURO-SKI
Phase 3 Completed
868 enrolled
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
Phase 3 Completed
177 enrolled 15 charts
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase 3 Completed
5,377 enrolled 18 charts
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Phase 3 Completed
3,154 enrolled 26 charts
Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Phase 3 Completed
166 enrolled 18 charts
Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)
Phase 1 Completed
104 enrolled 9 charts